Goldman Sachs upgrades Pinnacle West Capital (pnw) to buy
Goldman Sachs upgraded Pinnacle West Capital from Neutral to Buy with a $45 price target.
Goldman Sachs upgraded Johnson & Johnson from Neutral to Buy, while downgrading Bristol-Myers Squibb Co..